Fig. 2
From: Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus
Comparison of serum s-PCK1-Ab levels between healthy donors (HDs) and patients. The s-PCK1-Ab levels of HDs and patients with transient ischemic attack (TIA) or acute ischemic stroke (AIS) (a) and cardiovascular disease (CVD) or obstructive sleep apnea syndrome (OSAS), (b) were examined by AlphaLISA using glutathione S-transferase (GST)-PCK12-302 protein as the antigen, followed by subtraction of the levels against control GST. A scatter dot plot of the s-PCK1-Ab levels is shown as described in the legends of Fig. 1. The bars represent the average and average ± SD. P values were calculated using the Kruskal–Wallis test. *, P < 0.05 vs. HD specimens. ns, not significant. The total (male/female) numbers, average ages ± standard deviations (SDs), average antibody levels ± SDs, cutoff values, positive numbers, positive rates (%), and P values versus HDs are summarized and shown in Tables 2 and 3